Laurel Habel to Receptor, ErbB-2
This is a "connection" page, showing publications Laurel Habel has written about Receptor, ErbB-2.
Connection Strength
1.572
-
Reply to L. Cabel et al. J Clin Oncol. 2015 Jan 20; 33(3):292-3.
Score: 0.489
-
Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol. 2014 Jul 10; 32(20):2151-8.
Score: 0.471
-
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol. 2010 Oct 01; 28(28):4300-6.
Score: 0.362
-
Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care. 2012 Nov; 18(11):704-12.
Score: 0.106
-
Breast Cancer Recurrence by Subtype in a Diverse, Contemporary Cohort of Young Women. J Am Coll Surg. 2023 07 01; 237(1):13-23.
Score: 0.054
-
Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
Score: 0.031
-
Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
Score: 0.029
-
Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
Score: 0.029